Trials Of Marijuana's Medical Potential Languish As Government Just Says No

Government Just Says No Author: Peter Gwynne Can smoking marijuana help to alleviate the loss of appetite and weight that accompany AIDS? Much as they would like to know, people with AIDS and their physicians seem unlikely to get a definitive answer to that question any time in the near future. FIELD OF DREAMS: The University of Mississippi grows marijuana for NIDA, for use in reserach that meets the institute's criteria. For more than three years, a physician proposing to undertake a pilot

Written byPeter Gwynne
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Government Just Says No Author: Peter Gwynne

Can smoking marijuana help to alleviate the loss of appetite and weight that accompany AIDS? Much as they would like to know, people with AIDS and their physicians seem unlikely to get a definitive answer to that question any time in the near future.

field FIELD OF DREAMS: The University of Mississippi grows marijuana for NIDA, for use in reserach that meets the institute's criteria. For more than three years, a physician proposing to undertake a pilot clinical trial on pot treatment has consistently failed to receive from the federal government the marijuana necessary to carry out the trial, or federal approval to obtain nongovernment pot for it.

Researchers involved in the effort to start the experiment emphasize that nobody in government is singling out AIDS. At present, no trial for any other suggested medical use of marijuana-to treat the nausea associated with cancer ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies